Atossa Therapeutics
ATOS
#9381
Rank
NZ$0.15 B
Marketcap
NZ$1.17
Share price
-4.62%
Change (1 day)
-33.78%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -NZ$51.93 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$43.69 Million, an increase over its 2023 earnings that were of -NZ$51.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$51.93 Million18.87%
2024 -NZ$43.69 Million-15.25%
2023 -NZ$51.55 Million11.62%
2022 -NZ$46.18 Million30.84%
2021 -NZ$35.3 Million15.58%
2020 -NZ$30.54 Million3.41%
2019 -NZ$29.53 Million51.16%
2018 -NZ$19.54 Million40.41%
2017 -NZ$13.92 Million27.54%
2016 -NZ$10.91 Million-47.49%
2015 -NZ$20.78 Million-17.25%
2014 -NZ$25.11 Million35.91%
2013 -NZ$18.48 Million112.3%
2012 -NZ$8.71 Million46.53%
2011 -NZ$5.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$55.48 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.28 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.20 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-NZ$13.43 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$71.38 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-NZ$0.19 Billion 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA